MDM2 and lung cancer: The previously described miRNA:miRNA interaction involving miR-660-5p, MDM2 and miR-486-5p was proposed as a potential target for lung cancer therapy via the stabilisation of the tumour suppressor p53 (Borzi et al., 2017).